JOINT 22ND MEDICINES FOR EUROPE AND 19TH IGBA ANNUAL CONFERENCE
JUNE 8-10, 2016
The global value of generic, biosimilar and value added medicines
For the first time, Medicines for Europe and IGBA joined forces to create an opportunity to learn about global developments in generic, biosimilar and value added medicines. Our joint 22nd Medicines for Europe and 19th IGBA Annual Conference delivered a unique platform for you to meet and network with industry, regulators and key stakeholders from all over the world.
For more infomation please visit here.